Patients treated with 0.05% urcosimod demonstrated directionally favorable improvements in nerve fiber count and fiber length, trends not ...

Okyo Pharma (OKYO) announced new analyses of corneal images from the recently completed Phase 2 clinical trial of urcosimod in neuropathic corneal ...

Shares of Okyo Pharma were higher Thursday after the company reported favorable nerve-restoration data for its drug that treats neuropathic corneal pain. Shares climbed 15% to $2.32 and are up twofold ...

The latest announcement is out from OKYO Pharma Limited Sponsored ADR ( ($OKYO) ). On December 11, 2025, OKYO Pharma Limited ...

Nerve damage and a buildup of immune cells in the cornea may be a sign of "long COVID," a long-term syndrome that emerges in some people after COVID-19 infection, a new study suggests. These ...

Please provide your email address to receive an email when new articles are posted on . Women with epilepsy and hormonal irregularities had reduced nerve fiber length, reduced fractal dimension and ...

Consider the cornea if you will – and most people won't unless they're having a problem. It is the transparent front surface of the eye which allows vision by focusing light as it enters. The cornea ...

Pediatric Eye Specialists, a leading provider of pediatric ophthalmology services in North Texas, has published a new educational resource titled Pediatric Optic Nerve Hypoplasia (ONH) to help parents ...